This study aims to evaluate the safety and tolerability of RC1012 injection infusion in AML Patients after Allo-HSCT.~DNT cells are mature T lymphocytes that comprise 3-10% of T cells in human peripheral blood mononuclear cells (PBMC). Allo-DNT cells from healthy donors have been proved to be safe and demonstrated potent cytotoxicity against AML blasts from AML patients in preclinical and preliminary clinical studies. Allo-DNT cells will be collected from healthy donors (NO MHC match needed) and infused into patients. The drug for this study is an off-the-shelf product. Patients DO NOT need to wait for the cell manufacturing.
To evaluate the safety and tolerability of RC1012 injection infusion in AML Patients after Allo-HSCT